Detalhe da pesquisa
1.
2-weekly versus 3-weekly docetaxel for metastatic castration-resistant prostate cancer: complete quality of life results from the randomised, phase-III PROSTY trial.
Acta Oncol
; 61(8): 963-971, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35847998
2.
The Clip Approach: A Visual Methodology to Support the (Re)Construction of Life Narratives.
Qual Health Res
; 31(4): 789-803, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33570471
3.
Third-line treatment and 177Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review.
Eur J Nucl Med Mol Imaging
; 45(3): 496-508, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29247284
4.
Predictive and Prognostic Clinical Variables in Cancer Patients Treated With Adenoviral Oncolytic Immunotherapy.
Mol Ther
; 24(7): 1323-32, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27039846
5.
Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus.
Mol Ther
; 24(1): 175-83, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26310629
6.
Case-control estimation of the impact of oncolytic adenovirus on the survival of patients with refractory solid tumors.
Mol Ther
; 23(2): 321-9, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25381801
7.
Biodistribution Analysis of Oncolytic Adenoviruses in Patient Autopsy Samples Reveals Vascular Transduction of Noninjected Tumors and Tissues.
Mol Ther
; 23(10): 1641-52, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26156245
8.
T-cell subsets in peripheral blood and tumors of patients treated with oncolytic adenoviruses.
Mol Ther
; 23(5): 964-973, 2015 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25655312
9.
Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans.
Int J Cancer
; 137(7): 1775-83, 2015 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25821063
10.
VMAT technique enables concomitant radiotherapy of prostate cancer and pelvic bone metastases.
Acta Oncol
; 54(6): 847-53, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25307406
11.
Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans.
Int J Cancer
; 135(3): 720-30, 2014 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24374597
12.
Oncolytic adenovirus with temozolomide induces autophagy and antitumor immune responses in cancer patients.
Mol Ther
; 21(6): 1212-23, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23546299
13.
2-Weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer: a randomised, phase 3 trial.
Lancet Oncol
; 14(2): 117-24, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23294853
14.
Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatment.
J Transl Med
; 11: 193, 2013 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-23965133
15.
Verapamil results in increased blood levels of oncolytic adenovirus in treatment of patients with advanced cancer.
Mol Ther
; 20(1): 221-9, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22044933
16.
Ad3-hTERT-E1A, a fully serotype 3 oncolytic adenovirus, in patients with chemotherapy refractory cancer.
Mol Ther
; 20(9): 1821-30, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22871667
17.
Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors.
Int J Cancer
; 130(8): 1937-47, 2012 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21630267
18.
Immunological effects of low-dose cyclophosphamide in cancer patients treated with oncolytic adenovirus.
Mol Ther
; 19(9): 1737-46, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21673660
19.
Single Center Experience with a 4-Week 177Lu-PSMA-617 Treatment Interval in Patients with Metastatic Castration-Resistant Prostate Cancer.
Cancers (Basel)
; 14(24)2022 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36551641
20.
A Retrospective Comparative Study of Sodium Fluoride Na18F-PET/CT and 68Ga-PSMA-11 PET/CT in the Bone Metastases of Prostate Cancer Using a Volumetric 3-D Radiomic Analysis.
Life (Basel)
; 12(12)2022 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36556342